<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30674474</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Hypomethylation of <i>STAT1</i> and <i>HLA-DRB1</i> is associated with type-I interferon-dependent <i>HLA-DRB1</i> expression in lupus CD8+ T cells.</ArticleTitle><Pagination><StartPage>519</StartPage><EndPage>528</EndPage><MedlinePgn>519-528</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2018-214323</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We examined genome-wide DNA methylation changes in CD8+ T cells from patients with lupus and controls and investigated the functional relevance of some of these changes in lupus.</AbstractText><AbstractText Label="METHODS">Genome-wide DNA methylation of lupus and age, sex and ethnicity-matched control CD8+ T cells was measured using the Infinium MethylationEPIC arrays. Measurement of relevant cell subsets was performed via flow cytometry. Gene expression was quantified by qPCR. Inhibiting STAT1 and CIITA was performed using fludarabine and CIITA siRNA, respectively.</AbstractText><AbstractText Label="RESULTS">Lupus CD8+ T cells had 188 hypomethylated CpG sites compared with healthy matched controls. Among the most hypomethylated were sites associated with <i>HLA-DRB1</i>. Genes involved in the type-I interferon response, including <i>STAT1</i>, were also found to be hypomethylated. IFN&#x3b1; upregulated HLA-DRB1 expression on lupus but not control CD8+ T cells. Lupus and control CD8+ T cells significantly increased STAT1 mRNA levels after treatment with IFN&#x3b1;. The expression of CIITA, a key interferon/STAT1 dependent MHC-class II regulator, is induced by IFN&#x3b1; in lupus CD8+ T cells, but not healthy controls. CIITA knockdown and STAT1 inhibition experiments revealed that HLA-DRB1 expression in lupus CD8+ T cells is dependent on CIITA and STAT1 signalling. Coincubation of na&#xef;ve CD4+ T cells with IFN&#x3b1;-treated CD8+ T cells led to CD4+ T&#x2009;cell activation, determined by increased expression of CD69 and cytokine production, in patients with lupus but not in healthy controls. This can be blocked by neutralising antibodies targeting HLA-DR.</AbstractText><AbstractText Label="CONCLUSIONS">Lupus CD8+ T cells are epigenetically primed to respond to type-I interferon. We describe an HLA-DRB1+ CD8+ T&#x2009;cell subset that can be induced by IFN&#x3b1; in patients with lupus. A possible pathogenic role for CD8+ T cells in lupus that is dependent on a high type-I interferon environment and epigenetic priming warrants further characterisation.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Miller</LastName><ForeName>Shaylynn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tsou</LastName><ForeName>Pei-Suen</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coit</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gensterblum-Miller</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renauer</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohraff</LastName><ForeName>Dallas M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kilian</LastName><ForeName>Nathan C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schonfeld</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawalha</LastName><ForeName>Amr H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA asawalha@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI097134</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007413</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007080</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C083728">MHC class II transactivator protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050794">STAT1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494079">STAT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050794" MajorTopicYN="N">STAT1 Transcription Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8+ T cells</Keyword><Keyword MajorTopicYN="N">HLA-DRB1</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">epigenteic priming</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">lupus</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30674474</ArticleId><ArticleId IdType="mid">NIHMS1037960</ArticleId><ArticleId IdType="pmc">PMC6679955</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2018-214323</ArticleId><ArticleId IdType="pii">annrheumdis-2018-214323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coit P, Jeffries M, Altorok N, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in na&#xef;ve CD4+ T cells from lupus patients. J Autoimmun 2013;43:78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3790645</ArticleId><ArticleId IdType="pubmed">23623029</ArticleId></ArticleIdList></Reference><Reference><Citation>Coit P, Renauer P, Jeffries MA, et al. Renal involvement in lupus is characterized by unique DNA methylation changes in na&#xef;ve CD4+ T cells. J Autoimmun 2015;61:29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4497927</ArticleId><ArticleId IdType="pubmed">26005050</ArticleId></ArticleIdList></Reference><Reference><Citation>Renauer P, Coit P, Jeffries MA, et al. DNA methylation patterns in na&#xef;ve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus Sci Med 2015;2:e000101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4577980</ArticleId><ArticleId IdType="pubmed">26405558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Liu S, Luo S, et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 2014;54:127&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25091625</ArticleId></ArticleIdList></Reference><Reference><Citation>Absher DM, Li X, Waite LL, et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet 2013;9:e1003678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738443</ArticleId><ArticleId IdType="pubmed">23950730</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung KS, Chung BH-Y, Choufani S, et al. Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus identified Hypomethylation in Genes Related to the Type i interferon Pathway. Plos One 2017;12:e0169553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5234836</ArticleId><ArticleId IdType="pubmed">28085900</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Mi W, Luo H, et al. Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus. Arthritis Res Ther 2016;18:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942934</ArticleId><ArticleId IdType="pubmed">27412348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulff-M&#xf8;ller CJ, Asmar F, Liu Y, et al. Twin DNA Methylation Profiling Reveals Flare-Dependent Interferon Signature and B Cell Promoter Hypermethylation in Systemic Lupus Erythematosus. Arthritis Rheumatol 2018;70:878&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">29361205</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel M, Sawalha AH. Epigenetic Variability in Systemic Lupus Erythematosus: What We Learned from Genome-Wide DNA Methylation Studies. Curr Rheumatol Rep 2017;19:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5819620</ArticleId><ArticleId IdType="pubmed">28470479</ArticleId></ArticleIdList></Reference><Reference><Citation>Comte D, Karampetsou MP, Yoshida N, et al. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus. Arthritis Rheumatol 2017;69:1035&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5406259</ArticleId><ArticleId IdType="pubmed">28076903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai ZW, Kelly R, Winans T, et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. Lancet 2018;391:1186&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891154</ArticleId><ArticleId IdType="pubmed">29551338</ArticleId></ArticleIdList></Reference><Reference><Citation>Filaci G, Bacilieri S, Fravega M, et al. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J Immunol 2001;166:6452&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11342672</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco P, Pitard V, Viallard JF, et al. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:201&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">15641052</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan TE, Roman RM, Rudenga BJ, et al. Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum 2010;62:1693&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885535</ArticleId><ArticleId IdType="pubmed">20178121</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, James JA. Everyone comes from somewhere: systemic lupus erythematosus and Epstein-Barr virus induction of host interferon and humoral anti-Epstein-Barr nuclear antigen 1 immunity. Arthritis Rheum 2010;62:1571&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885576</ArticleId><ArticleId IdType="pubmed">20178135</ArticleId></ArticleIdList></Reference><Reference><Citation>James JA, Kaufman KM, Farris AD, et al. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC508514</ArticleId><ArticleId IdType="pubmed">9399948</ArticleId></ArticleIdList></Reference><Reference><Citation>James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001;44:1122&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11352244</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Chen X, Pujato M, et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet 2018;50:699&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6022759</ArticleId><ArticleId IdType="pubmed">29662164</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>McCune WJ, Golbus J, Zeldes W, et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988;318:1423&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">3259286</ArticleId></ArticleIdList></Reference><Reference><Citation>Amano H, Morimoto S, Kaneko H, et al. Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers. Lupus 2000;9:26&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">10713644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YI, Logan JW, Mason JB, et al. DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. J Lab Clin Med 1996;128:165&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">8765212</ArticleId></ArticleIdList></Reference><Reference><Citation>Renauer PA, Coit P, Sawalha AH. The DNA methylation signature of human TCR&#x3b1;&#x3b2;+CD4-CD8-double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol 2015;156:19&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4278938</ArticleId><ArticleId IdType="pubmed">25451162</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis G, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12734009</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins PA, Maino VC, Warner NL, et al. Activated T cells and monocytes have characteristic patterns of class II antigen expression. J Immunol 1988;141:1281&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">3135327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LY, Yim EKF, Choo ABH. Normalized median fluorescence: an alternative flow cytometry analysis method for tracking human embryonic stem cell states during differentiation. Tissue Eng Part C Methods 2013;19:156&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22838642</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson B, Scheinbart L, Strahler J, et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990;33:1665&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">2242063</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffries MA, Dozmorov M, Tang Y, et al. Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011;6:593&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3121972</ArticleId><ArticleId IdType="pubmed">21436623</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaks Z, Perl A. Metabolic control of the epigenome in systemic Lupus erythematosus. Autoimmunity 2014;47:256&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4034124</ArticleId><ArticleId IdType="pubmed">24128087</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan D, Meade G, Foley VM, et al. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001;360(Pt 1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1222196</ArticleId><ArticleId IdType="pubmed">11695986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lit LC, Wong CK, Tam LS, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006;65:209&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1798029</ArticleId><ArticleId IdType="pubmed">15975968</ArticleId></ArticleIdList></Reference><Reference><Citation>Vil&#xe1; LM, Molina MJ, Mayor AM, et al. Association of serum MiP-1alpha, MiP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol 2007;26:718&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16924394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni O, Pawar RD, Purschke W, et al. Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. J Am Soc Nephrol 2007;18:2350&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17625118</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo XY, Yuan JL, Liu J, et al. increased Macroautophagy in interferon-Gamma-Producing T Cells from Patients with Newly Diagnosed Systemic Lupus Erythematosus. Chin Med J 2018;131:1527&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6032673</ArticleId><ArticleId IdType="pubmed">29941705</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Lugo L, S&#xe1;enz-Garc&#xed;a J, Navarro Quiroz E, et al. Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus. Lupus 2018:961203318812679.</Citation><ArticleIdList><ArticleId IdType="pubmed">30453818</ArticleId></ArticleIdList></Reference><Reference><Citation>Au-Yeung N, Mandhana R, Horvath CM. Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway. JAKSTAT 2013;2:e23931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772101</ArticleId><ArticleId IdType="pubmed">24069549</ArticleId></ArticleIdList></Reference><Reference><Citation>LeibundGut-Landmann S, Waldburger JM, Krawczyk M, et al. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol 2004;34:1513&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15162420</ArticleId></ArticleIdList></Reference><Reference><Citation>Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996;84:431&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">8608597</ArticleId></ArticleIdList></Reference><Reference><Citation>Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005;5:793&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">16200082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramana CV, Chatterjee-Kishore M, Nguyen H, et al. Complex roles of Stat1 in regulating gene expression. Oncogene 2000;19:2619&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">10851061</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Leung S, Qureshi S, et al. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J Biol Chem 1996;271:5790&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">8621447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed RN, Watson HA, Vigar M, et al. L-selectin is Essential for Delivery of Activated CD8(+) T Cells to Virus-infected Organs for Protective immunity. Cell Rep 2016;14:760&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742564</ArticleId><ArticleId IdType="pubmed">26804910</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinoco R, Carrette F, Barraza ML, et al. PSGL-1 is an immune Checkpoint Regulator that Promotes T Cell Exhaustion. Immunity 2016;44:1190&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4908967</ArticleId><ArticleId IdType="pubmed">27192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Rodr&#xed;guez N, Apostolidis SA, Penaloza-MacMaster P, et al. Programmed cell death 1 and Helios distinguish TCR-&#x3b1;&#x3b2;+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells. J Immunol 2015;194:4207&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4503929</ArticleId><ArticleId IdType="pubmed">25825451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kis-Toth K, Comte D, Karampetsou MP, et al. Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus. Arthritis Rheumatol 2016;68:164&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690788</ArticleId><ArticleId IdType="pubmed">26314831</ArticleId></ArticleIdList></Reference><Reference><Citation>Viallard JF, Bloch-Michel C, Neau-Cransac M, et al. HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol 2001;125:485&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1906149</ArticleId><ArticleId IdType="pubmed">11531958</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Tsokos MG, Bickerton S, et al. Precision DNA demethylation ameliorates disease in lupus-prone mice. JCI Insight 2018;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6141184</ArticleId><ArticleId IdType="pubmed">30135300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kular L, Liu Y, Ruhrmann S, et al. DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. Nat Commun 2018;9:2397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6008330</ArticleId><ArticleId IdType="pubmed">29921915</ArticleId></ArticleIdList></Reference><Reference><Citation>ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>